Suspect in Therapist Killing Is Found Fit for Trial

This article is from the archive of The New York Sun before the launch of its new website in 2022. The Sun has neither altered nor updated such articles but will seek to correct any errors, mis-categorizations or other problems introduced during transfer.

The New York Sun

Two psychiatrists have determined that a man charged with hacking a Manhattan therapist to death with a meat cleaver is competent to stand trial, a judge said yesterday.

David Tarloff, 39, was ordered to undergo a psychiatric evaluation at his arraignment Sunday on second-degree murder and other charges.

At a hearing yesterday, Judge James Gibbons of Manhattan Criminal Court said the psychiatric report from Bellevue Hospital Center concluded that Mr. Tarloff “is not incapacitated — that is, the defendant is fit to stand trial.” The judge himself did not make a determination.

Earlier, a defense lawyer, Bryan Konoski, said he planned to ask the court to appoint another psychiatrist to examine Mr. Tarloff. Mr. Konoski was due back in court later Friday, along with prosecutor Evan Krutoy.

Mr. Tarloff was arrested February 16 after investigators matched his palm prints with those at the bloody Manhattan office where therapist Kathryn Faughey was slashed to death on February 12.

Police said Mr. Tarloff told investigators he had set out to rob a psychiatrist in the same suite of offices who had institutionalized him 17 years ago. The psychiatrist, Dr. Kent Shinbach, came to Faughey’s aid and was badly injured.

Police have not explained why Mr. Tarloff would have attacked Faughey, who was slashed 15 times with a meat cleaver and a 9-inch knife.


The New York Sun

© 2025 The New York Sun Company, LLC. All rights reserved.

Use of this site constitutes acceptance of our Terms of Use and Privacy Policy. The material on this site is protected by copyright law and may not be reproduced, distributed, transmitted, cached or otherwise used.

The New York Sun

Sign in or  Create a free account

or
By continuing you agree to our Privacy Policy and Terms of Use